Literature DB >> 24740532

Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration.

Caoyun Ju1, Ran Mo, Jingwei Xue, Lei Zhang, Zekai Zhao, Lingjing Xue, Qineng Ping, Can Zhang.   

Abstract

To achieve deep tumor penetration of large-sized nanoparticles (NPs), we have developed a reversible swelling-shrinking nanogel in response to pH variation for a sequential intra-intercellular NP delivery. The nanogel had a crosslinked polyelectrolyte core, consisting of N-lysinal-N'-succinyl chitosan and poly(N-isopropylacrylamide), and a crosslinked bovine serum albumin shell, which was able to swell in an acidic environment and shrink back under neutral conditions. The swelling resulted in a rapid release of the encapsulated chemotherapeutics in the cancer cells for efficient cytotoxicity. After being liberated from the dead cells, the contractive nanogel could infect neighboring cancer cells closer to the center of the tumor tissue.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antitumor agents; drug delivery; nanogels; pH responsive; tumor penetration

Mesh:

Substances:

Year:  2014        PMID: 24740532     DOI: 10.1002/anie.201311227

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  38 in total

1.  pH-Sensitive morphological transitions in polymeric tadpole assemblies for programmed tumor therapy.

Authors:  Cunfeng Song; Tongtong Lin; Qiang Zhang; S Thayumanavan; Lei Ren
Journal:  J Control Release       Date:  2018-11-01       Impact factor: 9.776

2.  Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.

Authors:  Xiaoding Xu; Phei Er Saw; Wei Tao; Yujing Li; Xiaoyuan Ji; Mikyung Yu; Morteza Mahmoudi; Jonathan Rasmussen; Dana Ayyash; Yuxiao Zhou; Omid C Farokhzad; Jinjun Shi
Journal:  Nano Lett       Date:  2017-06-26       Impact factor: 11.189

3.  Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.

Authors:  Jingwei Xue; Zekai Zhao; Lei Zhang; Lingjing Xue; Shiyang Shen; Yajing Wen; Zhuoyuan Wei; Lu Wang; Lingyi Kong; Hongbin Sun; Qineng Ping; Ran Mo; Can Zhang
Journal:  Nat Nanotechnol       Date:  2017-06-19       Impact factor: 39.213

4.  ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.

Authors:  Ran Mo; Tianyue Jiang; Wujin Sun; Zhen Gu
Journal:  Biomaterials       Date:  2015-02-14       Impact factor: 12.479

5.  A functional nanocarrier that copenetrates extracellular matrix and multiple layers of tumor cells for sequential and deep tumor autophagy inhibitor and chemotherapeutic delivery.

Authors:  Yang Wang; Yue Qiu; Sheng Yin; Li Zhang; Kairong Shi; Huile Gao; Zhirong Zhang; Qin He
Journal:  Autophagy       Date:  2016-12-02       Impact factor: 16.016

Review 6.  Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue.

Authors:  Muhammad Usman Munir
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 7.  Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriers.

Authors:  Jian-Ping Liu; Ting-Ting Wang; Dang-Ge Wang; An-Jie Dong; Ya-Ping Li; Hai-Jun Yu
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

Review 8.  Enhancing Tumor Penetration of Nanomedicines.

Authors:  Qingxue Sun; Tarun Ojha; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Biomacromolecules       Date:  2017-03-31       Impact factor: 6.988

Review 9.  Nanotechnology in the Treatment of Diabetic Complications: A Comprehensive Narrative Review.

Authors:  Yujing He; Abdulrahman Al-Mureish; Na Wu
Journal:  J Diabetes Res       Date:  2021-04-30       Impact factor: 4.011

10.  A multicomponent microemulsion using rational combination strategy improves lung cancer treatment through synergistic effects and deep tumor penetration.

Authors:  Ding Qu; Mengfei Guo; Yue Qin; Lixiang Wang; Bing Zong; Yunyan Chen; Yan Chen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.